Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
La tirzepatida (Mounjaro, Zepbound) es un agonista dual que acta sobre los receptores GIP/GLP-1, por lo que representa una terapia incretnica relacionada pero distinta
Approved in 2005 by the Food and Drug Administration, GLP-1 medications are known to treat type 2 diabetes by stimulating the body to produce more insulin, which in turn lowers blood sugar levels
Our clinical team focuses solely on weight loss, and is world class in that category
Final packaging should be confirmed during quote and supplier documentation review
US$ 25.98
US$ 21.58
US$ 23.52
US$ 26.29
